Abstract
Background: Abelmoschus esculentus (AE) (okra), is an edible plant used in many food applications.
Objective: This study explored whether sulfated AE (SAE) has promising cancer chemopreventive activities that may recommend it as a functional food supplement instead of (or in addition to) AE for the population at risk of cancer and in the health food industry.
Methods: Cytochrome P450-1A (CYP1A) was estimated by fluorescence enzymatic reaction, using β-naphthoflavone-treated cells (CYP1A inducer). Peroxyl and hydroxyl radical scavenging was assayed by oxygen radical absorbance capacity assay. Flow cytometry was used to analyze apoptosis/necrosis in MCF-7 cells, cell cycle phases in MCF-7 cells, and macrophage binding to fluorescein isothiocyanate-lipopolysaccharide (FITC-LPS). Nitric oxide was determined by Griess assay in LPS-stimulated macrophages, and cytotoxicity was determined by MTT assay. Diethylnitrosamine (DEN) was used to induce hepatic tumor initiation in rats. Placental glutathione-S-transferase (GSTP; an initiation marker) was stained in a fluorescence immunohistochemical analysis of liver sections, and histopathological changes were examined.
Results: SAE exhibited strong antitumor initiation and antitumor promotion activities. It suppressed CYP1A, scavenged peroxyl and hydroxyl radicals, induced macrophage proliferation, suppressed macrophage binding to FITC-LPS, inhibited nitric oxide generation, showed specific cytotoxicity to human breast MCF-7 adenocarcinoma cells, and disturbed the cell cycle phases (S and G2/M phases) in association with an increased percentage of apoptotic/necrotic MCF-7 cells. Over a short time period, DEN stimulated liver cancer initiation, but SAE treatment reduced the DEN-induced histopathological alterations and inhibited CYP1A and GSTP.
Conclusion: SAE extract has the potential for use as an alternative to AE in health foods to provide cancer chemoprevention in populations at risk for cancer.
Keywords: Abelmoschus esculentus, CYP1A, cancer chemoprevention, antitumor initiation in liver, GSTP, anticancer, MCF-7 cells.
Graphical Abstract
[http://dx.doi.org/10.1016/j.lab.2005.01.003] [PMID: 15871304]
[http://dx.doi.org/10.1016/S1053-4296(03)00024-9] [PMID: 12903014]
[http://dx.doi.org/10.4103/0975-7406.84447] [PMID: 21966160]
[http://dx.doi.org/10.1016/j.foodchem.2017.09.051] [PMID: 29037680]
[PMID: 22762057]
[http://dx.doi.org/10.1039/C5FO01214G] [PMID: 26787242]
[http://dx.doi.org/10.1016/j.carbpol.2013.02.041] [PMID: 23618310]
[http://dx.doi.org/10.1016/j.cbi.2006.03.010] [PMID: 16756967]
[http://dx.doi.org/10.4103/0250-474X.39438]
[PMID: 17466921]
[http://dx.doi.org/10.1016/S0008-6215(00)00315-3] [PMID: 11322734]
[http://dx.doi.org/10.1016/S0144-8617(02)00330-2]
[http://dx.doi.org/10.3891/acta.chem.scand.20-0219]
[http://dx.doi.org/10.1039/an9800500083]
[http://dx.doi.org/10.1038/164443a0]
[http://dx.doi.org/10.1006/abio.1997.2145] [PMID: 9177742]
[http://dx.doi.org/10.1016/S0021-9258(19)42083-8] [PMID: 4436300]
[http://dx.doi.org/10.1016/S0076-6879(99)99008-0] [PMID: 9916196]
[http://dx.doi.org/10.1016/0022-1759(89)90397-9] [PMID: 2470825]
[http://dx.doi.org/10.1016/S0039-9140(01)00323-X]
[http://dx.doi.org/10.1093/ndt/17.3.428] [PMID: 11865088]
[http://dx.doi.org/10.1080/01635581.2011.538953] [PMID: 21500099]
[http://dx.doi.org/10.1016/S0098-2997(00)00007-8] [PMID: 11173079]
[http://dx.doi.org/10.1016/j.bcp.2006.02.009] [PMID: 16563357]
[http://dx.doi.org/10.3109/08923970903440192]
[http://dx.doi.org/10.1159/000058750] [PMID: 10608082]
[http://dx.doi.org/10.1155/2011/603740] [PMID: 21772845]
[http://dx.doi.org/10.1016/j.mehy.2011.04.009] [PMID: 21550177]
[http://dx.doi.org/10.1042/BSR20180992] [PMID: 30530866]
[http://dx.doi.org/10.1093/carcin/8.3.483] [PMID: 3815743]
[http://dx.doi.org/10.1093/carcin/10.11.2107] [PMID: 2805231]
[http://dx.doi.org/10.1080/07357900701208733] [PMID: 17530489]
[http://dx.doi.org/10.1016/j.taap.2010.04.016] [PMID: 20423715]
[PMID: 12597451]